Targeting the vaginal microbiota with probiotics as a means to counteract infections

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 6, 2009, Pages 583-587

  Reid, Gregor ^a,b   Dols, Joke ^c   Miller, Wayne ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; PROBIOTIC AGENT;

HUMAN; INFECTION PREVENTION; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; REVIEW; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; VAGINA FLORA; VAGINITIS;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LACTOBACILLUS; MICROBIAL INTERACTIONS; PROBIOTICS; URINARY TRACT INFECTIONS; UROGENITAL SYSTEM; VAGINA; VAGINOSIS, BACTERIAL;

BACTERIA (MICROORGANISMS);

EID: 70350129057     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328331b611     Document Type: Review

References (30)

1. Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003; 69:97-101.
2. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353:1899-1911.
3. YamamotoT, Zhou X, Williams CJ, et al. Bacterial populations in the vaginas of healthy adolescent women. J Pediatr Adolesc Gynecol 2009; 22:11-18.
4. Schellenberg J, Links MG, Hill JE, et al. Pyrosequencing of the chaperonin-60 universal target as a tool for determining microbial community composition. Appl Environ Microbiol 2009; 75:2889-2898.
5. Kim TK, Thomas SM, Ho M, et al. Heterogeneity of vaginal microbial com-munities within individuals. J Clin Microbiol 2009; 47:1181-1189.
6. Burton JP, Devillard E, Cadieux PA, et al. Detection of Atopobium vaginae in post menopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol 2004;42:1829-1831.
7. Tamrakar R, Yamada T, Furuta I, et al. Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis 2007; 7:128.
8. Velraeds MM, van de Belt-Gritter B, van der Mei HC, et al. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 1998; 47:1081-1085.
9. Ekmekci H, Aslim B, Ozturk S. Characterization of vaginal lactobacilli coag-gregation ability with Escherichia coli. Microbiol Immunol 2009; 53:59-65.
10. Laughton JM, Devillard E, Heinrichs DE, et al. Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology 2006; 152 (Pt 4):1155-1167.
11. Voltan S, Martines D, Elli M, et al. Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Gastroenterology 2008; 135:1216-1227.
12. Martins AJ, Colquhoun P, Reid G, Kim SO. Reduced expression of basal and probiotic-inducible G-CSF in intestinal mononuclear cells is associated with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:515-525.
13. Kirjavainen PK, Laine RM, Carter D, et al. Expression of antimicrobial defense factors in vaginal mucosa following exposure to Lactobacillus rhamnosus GR-1. Int J Probiotics 2008; 3:99-106.
14. Saunders S, Bocking A, Challis J, Reid G. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces 2007; 55:138-142.
15. Witkin SS, Linhares IM, Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol 2007; 21:347-354.
16. Witkin SS, Linhares IM, Giraldo P, Ledger WJ. An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin Infect Dis 2007; 44:554-557.
17. Anukam K, Osazuwa E, Ahonkhai I, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteriRC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006; 8:1450-1454.
18. Martinez RC, Franceschini SA, Patta MC, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2g) and Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009; 55:133-138.
19. Martinez RC, Franceschini SA, Patta MC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rham nosus GR-1 and Lactobacillus reuteri RC-14. Letts Appl Microbiol 2009; 48:269-274.
20. Anukam KC, Duru MU, Eze CC, et al. Oral use of probiotics as an adjunctive therapy to fluconazole in the treatment of yeast vaginitis: a study of Nigerian women in an outdoor clinic. Microbial Ecol Health Dis 2009; 21:72-77.
21. Anukam KC, Reid G. Effects of metronidazole on growth of Gardnerella vaginalis ATCC 14018, probiotic Lactobacillus rhamnosus GR-1 and vaginal isolate Lactobacillus plantarum KCA. Microbial Ecol Health Dis 2008; 20:48-52.
22. Reid G, Charbonneau D, Erb J. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003; 35:131-134.
23. Martinez RC, Mifflin S, Summers KL, et al. Modulation of in vitro Candida albicans infection by Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Microbiol Immunol 2009. [Epub ahead of print]
24. Anukam KC, Osazuwa E, Osemene GI, et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006; 8:2772-2776.
25. Yeganegi M, Watson CS, Martins A, et al. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labour. Am J Obstetr Gynecol 2009; 200:532e1-5328e.
26. Wilson JD, Ralph SG, Rutherford AJ. Rates of bacterial vaginosis in women undergoing in vitro fertilisation for different types of infertility. BJOG 2002; 109:714-717.
27. Jakobsson T, Forsum U. Changes in the predominant human Lactobacillus flora during in vitro fertilisation. Ann Clin Microbiol Antimicrob 2008; 7:14.
28. Kirjavainen P, Pautler S, Baroja ML. Aberrant vaginal microbiota and IL-12 skewed cytokine production by antigen-presenting cells are characteristic of women prone to urinary tract infections. Clin Vaccine Immunol 2008;16:29-36.
29. Bruce AW, Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 1988; 34:339-343.
30. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008; 8:3.